SouthState Corp’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.52K | Sell |
100
-220
| -69% | -$11.9K | ﹤0.01% | 748 |
|
|
2025
Q4 | $15.7K | Sell |
320
-30
| -9% | -$1.4K | ﹤0.01% | 613 |
|
|
2025
Q3 | $15.1K | Sell |
350
-86
| -20% | -$3.36K | ﹤0.01% | 609 |
|
|
2025
Q2 | $16.7K | Buy |
+436
| New | +$16.7K | ﹤0.01% | 688 |
|
|
2024
Q2 | – | Sell |
-532
| Closed | -$22.8K | – | 694 |
|
|
2024
Q1 | $22.8K | Buy |
532
+40
| +8% | +$1.65K | ﹤0.01% | 441 |
|
|
2023
Q4 | $18.2K | Hold |
492
| – | – | ﹤0.01% | 429 |
|
|
2023
Q3 | $17.8K | Hold |
492
| – | – | ﹤0.01% | 417 |
|
|
2023
Q2 | $17.5K | Hold |
492
| – | – | ﹤0.01% | 428 |
|
|
2023
Q1 | $17.5K | Hold |
492
| – | – | ﹤0.01% | 454 |
|
|
2022
Q4 | $17.3K | Buy |
+492
| New | +$16.4K | ﹤0.01% | 486 |
|
|
2022
Q3 | – | Sell |
-892
| Closed | -$49K | – | 703 |
|
|
2022
Q2 | $49K | Buy |
892
+120
| +16% | +$6.63K | ﹤0.01% | 403 |
|
|
2022
Q1 | $42K | Hold |
772
| – | – | ﹤0.01% | 451 |
|
|
2021
Q4 | $43K | Hold |
772
| – | – | ﹤0.01% | 417 |
|
|
2021
Q3 | $37K | Buy |
+772
| New | +$38.8K | ﹤0.01% | 382 |
|
|
2020
Q4 | – | Sell |
-1,900
| Closed | -$90K | – | 339 |
|
|
2020
Q3 | $90K | Buy |
+1,900
| New | +$95.2K | 0.01% | 254 |
|
|
2017
Q1 | – | Sell |
-11,910
| Closed | -$574K | – | 250 |
|
|
2016
Q4 | $574K | Sell |
11,910
-19,798
| -62% | -$978K | 0.08% | 158 |
|
|
2016
Q3 | $1.71M | Sell |
31,708
-2,475
| -7% | -$136K | 0.26% | 100 |
|
|
2016
Q2 | $1.85M | Sell |
34,183
-469
| -1% | -$24.7K | 0.28% | 95 |
|
|
2016
Q1 | $1.76M | Sell |
34,652
-5,500
| -14% | -$274K | 0.27% | 99 |
|
|
2015
Q4 | $2.02M | Sell |
40,152
-9,516
| -19% | -$485K | 0.32% | 96 |
|
|
2015
Q3 | $2.39M | Sell |
49,668
-8
| -0% | -$416 | 0.36% | 93 |
|
|
2015
Q2 | $2.59M | Buy |
49,676
+8,160
| +20% | +$459K | 0.36% | 89 |
|
|
2015
Q1 | $2.4M | Sell |
41,516
-492
| -1% | -$28.2K | 0.34% | 91 |
|
|
2014
Q4 | $2.24M | Buy |
42,008
+3,420
| +9% | +$191K | 0.35% | 86 |
|
|
2014
Q3 | $2.22M | Buy |
38,588
+2,206
| +6% | +$135K | 0.34% | 89 |
|
|
2014
Q2 | $2.43M | Buy |
36,382
+796
| +2% | +$53.9K | 0.4% | 83 |
|
|
2014
Q1 | $2.38M | Buy |
35,586
+196
| +0.6% | +$13.3K | 0.38% | 88 |
|
|
2013
Q4 | $2.36M | Buy |
35,390
+1,718
| +5% | +$111K | 0.39% | 82 |
|
|
2013
Q3 | $2.11M | Buy |
33,672
+2,240
| +7% | +$144K | 0.39% | 83 |
|
|
2013
Q2 | $1.96M | Buy |
+31,432
| New | +$1.99M | 0.42% | 76 |
|
Other funds holding GSK
JEST
SouthState Corp's GSK Position: Q1 2026 in Review
SouthState Corp reduced its GSK (GSK) stake by 69% in Q1 2026, selling an estimated $11.9K and leaving 100 shares worth $5.52K. The position accounts for ﹤0.01% of the portfolio, ranked #748.
SouthState Corp first reported a position in GSK in Q2 2013 and has held it in 30 quarters since. The position peaked at $2.59M in Q2 2015. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- SouthState Corp held 100 shares of GSK worth $5.52K as of Q1 2026.
- SouthState Corp sold 220 GSK shares in Q1 2026, an estimated $11.9K.
- GSK made up ﹤0.01% of SouthState Corp's portfolio in Q1 2026, its #748 holding.
- SouthState Corp first reported a position in GSK in Q2 2013 and has held it in 30 quarters since.
- SouthState Corp's GSK position peaked at $2.59M in Q2 2015.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.